Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XBI vs. IBB: which is better?

Bottom line

XBI vs IBB: the short answer

XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and IBB (iShares Biotechnology ETF) are quite different portfolios: only about 4% of their top holdings (by weight) are shared.

XBI is cheaper at 0.35% vs 0.44% — a difference of $9.00 a year per $10,000 invested.

Over five years, IBB returned +2.5% a year vs −2.7% for XBI.

Updated Nov 19, 2026

XBI vs IBB side by side

XBIIBB
TypeETFETF
Fund familySPDR (State Street)iShares
CategoryTechnology SectorTechnology Sector
Expense ratio0.35%0.44%
Annual cost per $10k$35$44
10-yr cost on $10k (prospectus)$443$555
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+35.8%+28.0%
5-yr return (annualized)−2.7%+2.5%
10-yr return (annualized)+5.8%+4.4%
Best quarter+44.4%+26.8%
Worst quarter−26.2%−22.9%
Net assets (fund)$10.7B$5.9B
Number of holdings161254
Portfolio turnover71%27%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXBIIBBDifference
2025+35.8%+28.0%+7.8%
2024+1.1%−2.4%+3.5%
2023+7.5%+3.6%+3.9%
2022−25.8%−13.6%−12.2%
2021−20.5%+1.0%−21.5%
2020+48.2%+25.9%+22.3%
2019+32.2%+24.8%+7.5%
2018−14.9%−9.1%−5.8%
2017+43.7%+21.2%+22.5%
2016−15.4%−21.5%+6.1%

Source: Fund prospectus bar charts

Holdings overlap

2 of XBI's top 25 holdings also appear in IBB's top 25.

Shared top holdings
HoldingXBIIBB
Moderna Inc1.41%0.88%
Natera Inc1.16%2.11%

Source: SEC Form N-PORT

XBI top 10

  1. State Street Global Advisors — 5.87%
  2. Apogee Therapeutics Inc — 1.49%
  3. Moderna Inc — 1.41%
  4. Twist Bioscience Corp — 1.41%
  5. Oruka Therapeutics Inc — 1.38%
  6. Kymera Therapeutics Inc — 1.36%
  7. Viking Therapeutics Inc — 1.30%
  8. Praxis Precision Medicines Inc — 1.29%
  9. Erasca Inc — 1.27%
  10. Revolution Medicines Inc — 1.20%

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FAQ

What is the difference between XBI and IBB?
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and IBB (iShares Biotechnology ETF) are quite different portfolios: only about 4% of their top holdings (by weight) are shared. XBI is cheaper at 0.35% vs 0.44% — a difference of $9.00 a year per $10,000 invested.
Which is cheaper, XBI or IBB?
XBI has the lower expense ratio (0.35%).
Should I own both XBI and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.